This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Annovis Bio advances Alzheimer's Phase 3 trial: 76 sites secured, 38 patients dosed, financial position strengthens with strategic IP expansion and focused research #Alzheimers #Biotech
2025-08-13T16:58:04.408Z